- Home
- ELVN vs EXK Comparison
ELVN vs EXK Comparison
Compare ELVN & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | EXK |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ELVN | EXK |
|---|---|---|
| Price | $53.59 | $7.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $43.40 | $13.94 |
| AVG Volume (30 Days) | 1.8M | ★ 5.5M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.59 |
| Revenue Next Year | N/A | $17.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $4.91 |
| 52 Week High | $53.89 | $15.15 |
Technical Indicators
Market Signals| Indicator | ELVN | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 65.59 | 38.54 |
| Support Level | $25.63 | $7.43 |
| Resistance Level | N/A | $8.43 |
| Average True Range (ATR) | 2.56 | 0.43 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 95.86 | 14.17 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.